Monro, Inc. adopts one-year poison pill after Icahn's ~17% stake; trigger at 17.5%

MONRO, INC.

Icahn Enterprises L.P. accumulated ~17% beneficial ownership of Monro common stock, prompting the rights plan.
Rights Plan expires on Nov 6, 2026; triggers at 17.5% ownership threshold; exercise price $90 per right.
Each outstanding share will receive one right as of Nov 24, 2025 record date; rights separate after distribution date.
Upon trigger, rights become exercisable for shares worth twice the exercise price, diluting acquirer.
Board can redeem rights at $0.01 per right or exchange for common stock before trigger.

item 1.01 item 3.03 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MONRO, INC.: Certificate of Amendment to the Certificate of Incorporation filed in connection with the Rights Agreement (effective 2025-11-10).

Change: charter amendment
Effective: 2025-11-10

Exact text from the filing

the Board approved a Certificate of Amendment to the Certificate of Incorporation of the Company (the “ Certificate of Amendment ”). The Certificate of Amendment was filed with the Department of State of the State of New York and became effective on November 10, 2025.

View on SEC.gov

241 governance changes filed in the last 30 days. Browse all governance changes →

MONRO, INC. filing history →

Source: SEC EDGAR

accession 0001193125-25-274495

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.